Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)

被引：0
|
作者：
Jo, Jae-Cheol [1 ]
Kim, Jin-Seok [2 ]
Lee, Je-Hwan [3 ]
Lee, Jung-Hee [3 ]
Im, Seong Nam [4 ]
Lee, Won-Sik [5 ]
Lee, Sang-Min [5 ]
Yoon, Sung-Soo [6 ]
Kim, In-Ho [6 ]
Choi, Yun Suk [1 ]
Bae, Seong Hwa [7 ]
机构：
[1] Univ Ulsan, Coll Med Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea
[2] Yeonsei Univ, Severance Hosp, Coll Med 2, Seoul, South Korea
[3] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Inje Univ, Haeundae Paik Hosp, Coll Med, Busan, South Korea
[5] Inje Univ, Busan Paik Hosp, Coll Med, Busan, South Korea
[6] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea
[7] Daegu Catholic Univ, Coll Med, Med Ctr, Daegu, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P106
引用
下载
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jae-Cheol Jo
    Jin Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Sung-Nam Lim
    Sang Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Sung Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Bone Marrow Transplantation, 2020, 55 : 1466 - 1468
  • [2] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [3] Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma
    Garciaz, Sylvain
    Coso, Diane
    Broussais, Florence
    Schiano, Jean-Marc
    Calmels, Boris
    Saillard, Colombe
    Boudin, Lauris
    Amrane, Sophie
    Blaise, Didier
    Bouabdallah, Reda
    BLOOD, 2014, 124 (21)
  • [4] Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma
    Keil, F.
    Noesslinger, T.
    Unteregger, M. J.
    Moestl, M.
    Tinchon, C.
    Koller, E.
    Mulabecirovic, A.
    Hundsamer, A.
    Linkesch, W.
    ONKOLOGIE, 2012, 35 : 42 - 42
  • [5] Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma
    Noesslinger, T.
    Keil, F.
    Moestl, M.
    Tinchon, C.
    Koller, E.
    Mulabecirovic, A.
    Unteregger, M. J.
    Hundsamer, A.
    Sallaberger, E.
    Linkesch, W.
    ONKOLOGIE, 2013, 36 : 7 - 7
  • [6] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [7] AUTOLOGOUS STEM CELL TRANSPLANTATION WITH BEEAM (BENDAMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN) IN AGGRESSIVE NHL AND HODGKIN'S LYMPHOMA
    Noesslinger, T.
    Moestl, M.
    Koller, E.
    Tinchon, C.
    Mulabecirovic, A.
    Linkesch, W.
    Sallaberger, E.
    Hundsamer, A.
    Keil, F.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S167 - S168
  • [8] High-dose etoposide, cytarabine and melphalan as conditioning regimen for autologous stem cell transplantation in patients with refractory or relapsed Hodgkin's lymphoma
    Bekadja, M. A.
    Osmani, S.
    Brahimi, M.
    Talhi, S.
    Bekadja, S.
    Belkhodja, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S446 - S446
  • [9] Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma
    Kim, Ji-Won
    Lee, Hyun Jung
    Yi, Hyeon Gyu
    Kim, Byung-Su
    Bang, Soo-Mee
    Kim, Jin Seok
    Kim, Inho
    Yoon, Sung-Soo
    Lee, Jong Seok
    Kim, Chul Soo
    Park, Seonyang
    Kim, Byoung Kook
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (05) : 479 - 483
  • [10] TEAM (thiotepa, etoposide, cytarabine, melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M.
    Merla, E.
    Dell'Olio, M.
    Scalzulli, P.
    Capalbo, S.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S214 - S214
12345